← Open Payments lookup

MARY HETTICH-KELLY: Open Payments

NPI 1790810257 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$510 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $510

Food & beverage: $510
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.6$193
Otsuka America Pharmaceutical, Inc.2$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$64
E.R. Squibb & Sons, L.L.C.2$60
Lundbeck LLC1$28
ABBVIE INC.1$23
Alkermes, Inc.1$23
Luye Pharma (USA) Ltd.1$21
Janssen Pharmaceuticals, Inc1$19
Collegium Pharmaceutical, Inc.1$14

Products named: FANAPT, REXULTI, CAPLYTA, COBENFY, VRAYLAR, ARISTADA, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA.

Industry payments across MA — which companies pay providers there.